Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars

ConditionsPulpotomy Deep Caries

Trial statusNot yet recruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age6-8

SponsorCairo University

About this trial

The present study aims to evaluate the clinical and radiographic success of bioceramics putty MTA versus MTA in the pulpotomy of immature permanent molars

The main question it aims to answer is:

Will the biocermaics putty MTA have higher clinical and radiographic success rates than MTA in pulpotomy of immature permanent molars?

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients aged from 6-8 years of both sexes have immature permanent molars

with deep carious lesions indicated for pulpotomy.

Restorable young permanent molars with no clinical symptoms of irreversible pulpitis.

Permanent molars without any clinical sign of pulp necrosis including swelling, fistula, pain on percussion, and pathologic tooth mobility.

Disqualifiers

Medically compromised patients who have systemic disease.

Uncooperative patients who refuse treatment.

Permanent molars that were previously restored.

Trial design

Design model

Parallel

Treatments tested in this trial

premixed Bio-ceramic MTA
Drug
pulpotomy treatment will be done and the premixed bioceramic MTA will be applied in the pulp chamber
Conventional MTA
Drug
pulpotomy treatment will be done and powder and liquid MTA will be mixed and applied in the pulp chamber

Treatment groups

40 Participants

are divided into 2 treatment groups

Group A: control GroupActive comparator 1 intervention

Group B: ExperimentalExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Primary Outcome

Immediate Postoperative pain \[ Time Frame: one week) post operative pain by Verbal analogue scale.It is a 10 cm long horizontal line with points labeled from 0 to 10 where (0) indicates no pain, (1-3) mild pain, (4-6) moderate pain, and (7-10) severe pain.

Time frame

24hrs, 1 week

Secondary outcomes

Secondary outcome

The increase in root length, The root lengthening will be assessed in Mm through Digora software

Time frame

6,12 month

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: